About all

Tincture of belladonna: Belladonna Tincture Uses, Side Effects & Warnings

Case Report: Accidental overdose in the deep shade of night: a warning on the assumed safety of ‘natural substances’

  • Journal List
  • BMJ Case Rep
  • PMC4654174

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.

Learn more about our disclaimer.

BMJ Case Rep. 2015; 2015: bcr2015209333.

Published online 2015 Oct 22. doi: 10.1136/bcr-2015-209333

Case Report

Author information Article notes Copyright and License information Disclaimer

There is an increasing use of herbal remedies and medicines, with a commonly held belief that natural substances are safe. We present the case of a 50-year-old woman who was a trained herbalist and had purchased an ‘Atropa belladonna (deadly nightshade) preparation’. Attempting to combat her insomnia, late one evening she deliberately ingested a small portion of this, approximately 50 mL. Unintentionally, this was equivalent to a very large (15 mg) dose of atropine and she presented in an acute anticholinergic syndrome (confused, tachycardic and hypertensive) to our accident and emergency department. She received supportive management in our intensive treatment unit including mechanical ventilation. Fortunately, there were no long-term sequelae from this episode. However, this dramatic clinical presentation does highlight the potential dangers posed by herbal remedies. Furthermore, this case provides clinicians with an important insight into potentially dangerous products available legally within the UK. To help clinicians’ understanding of this our discussion explains the manufacture and ‘dosing’ of the A. belladonna preparation.

Atropa belladonna’, or ‘deadly nightshade’, is often associated with literary references describing the use of the plant by women to induce mydriasis to make themselves appear more seductive. Atropine is commonly used in Western medicine, for example, in the treatment of bradycardia. In herbal medicine, the anticholinergic effects of A. belladonna are used to alleviate ‘nervous’ pain, muscle spasm and to reduce secretions. Most cases of belladonna poisoning occur from direct ingestion of the plant’s berries.1 However, our case report describes the first published account of accidental atropine poisoning where atropine was obtained for professional herbalist purposes. It therefore highlights important safety considerations. The product involved was purchased legally for the intended beneficial effects, yet a small volume, just 50 mL, was able to produce almost fatal effects.

A 50-year-old woman presented confused (Glasgow Coma Scale 7/15), flushed and tachycardic (heart rate 163 bpm) to our emergency department.

Her husband explained that she had long-standing insomnia and, as normal for her, despite 7.5 mg of zopiclone, she had remained unsettled and withdrew downstairs. After hearing a commotion, the husband went downstairs to find his wife in a ‘giggling’ and intoxicated state (she had a long-standing abstinence from alcohol). He therefore helped her to bed. However, he was woken a second time when she had left the bed and fallen; this time she was more overtly confused, so an ambulance was called.

In the resuscitation room, the patient was tachycardic, hypertensive (180/110) and confused. Furthermore, she was flushed and sweaty though normothermic, and had bilateral dilated and slowly responding pupils. Given the severity of her agitation and diagnostic uncertainty, a modified rapid sequence intubation was undertaken. Intubation and sedation facilitated a safe transfer to the CT scanner, which revealed a normal CT of the brain. Then she was admitted to the intensive care unit for overnight care.

Over the following 6 h, her tachycardia improved from 130 to 105 and on sedation hold in the morning she was entirely appropriate, allowing for successful extubation. This allowed for a collateral history regarding the events of the previous night. She was a trained herbalist and had purchased ‘Atropa belladonna preparation’. During the night, to combat her insomnia, she had taken a drink directly from the bottle. This produced the dramatic anticholinergic poisoning syndrome described above.

Atropine acts as a competitive antagonist for the muscarinic acetylcholine receptors. Therefore, at its poisoning dose, it produces an almost complete block of the parasympathetic nervous system. This allows the symptoms to be predicted with the classic descriptive terms presented in .23

Table 1

Symptoms of anticholinergic syndrome

Red as a beetCompensating for the loss of sweat leads to excessive vasodilation of the skin to maximise heat loss
Dry as a boneMuscarinic action causes sweat glands to activate, therefore, anticholinergics cause anhidrosis (absence of sweat)
Hot as a hareThe removal of the normal thermal haemostasis mechanisms often results in high fever
Blind as a batPupillary constriction and accommodation rely on muscarinic receptors, therefore, anticholinergics cause pupillary dilation and blurry vision
Mad as a hatterThe loss of central nervous system muscarinic receptor action can lead to a range of symptoms from anxiety, delirium, visual hallucinations through to seizures and coma
Full as a drumBoth the detrusor muscle and urinary sphincter are under muscarinic control and therefore anticholinergics will lead to a decreased signal to urinate and an increase in urinary retention
Non-mnemonicLoss of muscarinic receptors means there is unopposed sympathetic action on the heart, giving tachycardia. There is also slowing (or complete absence) of bowel sounds

Open in a separate window

Most cases of atropine poisoning, intentional or otherwise, occur due to the ingestion of berries or plant material. Children are often poisoned by inadvertently ingesting A. belladonna berries. The subsequent anticholinergic toxidrome can have varying degrees of severity.4 Adult atropine poisoning is less commonly reported. Cases of mistaking A. belladonna for blueberries, or deliberate ingestion to cause self-harm, have been reported.4–6 Atropine poisoning has also been associated with rhabdomyolysis, pancreatitis and a subdural haematoma.7

However, given the wide variety of symptoms mentioned above, any condition that can cause a combination of tachycardia, altered mental status, urinary retention and possibly seizures can be included in the differential diagnosis of atropine poisoning.8

We will consider, first, other poisons that can mimic this and, second, non-poisoning differential diagnoses.

Some poisons will cause a true anticholinergic response. In our case, the plant was deadly nightshade, however, there are also woody and common nightshade plants.4 Furthermore Jimson weed9 (a plant occasionally smoked recreationally) contains anticholinergic alkaloids at high enough concentration to poison. Finally medicinal atropine (or other anticholinergic drugs) can be taken in overdose through accident or intentionally.141011 More commonly, though, poisons will have a degree of anticholinergic response but also other effects. The most significant class of drugs of this type are the tricyclic antidepressants. Although they will cause an anticholinergic syndrome, their effects on cardiac sodium channels cause the classic QRS prolongation and their α-blockade can result in significant hypotension.12 These clinical aspects tend to predominate in their poisoning. Phenothiazine derived drugs also cause anticholinergic affects. 13 This chemical class makes up a variety of antihistamine (eg, prochlorperazine) and antipsychotic (eg, chlorpromazine) medications. Although theoretically use of these substances could present as an anticholinergic syndrome, their hypotensive and sedating actions tend to predominate. Many of the symptoms from anticholinergic poisoning result from unopposed sympathetic system activity, therefore, poisoning by sympathomimetics can result in a very similar clinical paradigm. Hence, overdose of methamphetamine,14 cocaine,15 or even cough mixtures (due to the phenylephrine) are an important differential; however, a key difference is that these all tend to produce excessive sweating and the mydriasis is less marked. Furthermore, methamphetamines often present with more prominent psychosis and cocaine is marked by extreme hypertension and restlessness. A final key overdose differential in a patient who is hyperthermic, agitated and tachycardic, is salicylate poisoning. This in part is because of the ease of its supply. Aspirin poisoning tends to produce tinnitus, nausea and the classical blood gas changes of progression from respiratory alkalosis to metabolic acidosis, all of which can differentiate it from the anticholinergic poisonings.16

Important non-overdose differentials to consider include sepsis (particularly from a neurological source), serotonin syndrome and neuroleptic malignant syndrome. Central nervous system (CNS) infection can cause all the symptoms listed above but the temporal progression of the symptoms can often help differentiate this; the delirium associated with anticholinergic poisonings tends to have a sharp onset time as opposed to a more gradual action of inflammatory processes. Serotonin syndrome occurs in response to excessive CNS serotonin levels.17 This can be seen in overdose of the selective serotonin reuptake inhibitors (SSRIs), but their very large therapeutic window makes this a rare presentation. Therefore, it is more commonly seen as a side effect when SSRIs are taken over a longer period of time and augmented either by a dose increase or further medications (eg, ondansetron). It can also be seen in Carcinoid syndrome from serotonin-secreting tumours. Serotonin syndrome will result in a flushed, agitated and hyperpyrexic patient. However, it also causes sweating and neuromuscular hyper-reactivity (tremor, hyper-reflexia, myoclonus), which differentiate it from anticholinergic poisoning. Finally, neuroleptic malignant syndrome is a key differential.1819 This rare syndrome can occur with any of the antipsychotic medications or on withdrawal of Parkinson’s treatments. The pathogenesis is thought to revolve around dopamine inactivity in the hypothalamus (either via receptor blockade or loss of substrate, respectively). This causes a hyperpyrexia, autonomic dysregulation (mimicking any of the symptoms above) and Parkinson’s symptoms. These latter symptoms again act as a differentiator from both anticholinergic poisoning and also serotonin syndrome. 1819

As mentioned in our case presentation, she was suffering from very severe agitation. Therefore, to ensure her safety, and to facilitate safe investigation of her state, we proceeded to immediate intubation. We performed this using 100 μg fentanyl, 170 mg propofol and 60 mg rocuronium, sedation was then maintained with propofol and fentanyl infusions (12 mg/h and 50 μg/h, respectively). During her 10 h of treatment, 4.5 L of crystalloid rehydration occurred.

However, in most cases of atropine poising, the cerebral side effects are not so severe as to merit immediate sedation and airway protection. Indeed, as shown in , this is a marker of very severe overdose.

Table 2

Symptoms by severity of atropine poisoning (modified from Toxnet)20

Mild symptomsModerate symptomsSevere symptoms
Dry mouth, urinary retention and constipationSomnolence, classical mydriasis, flushing, fever and anhidrosis. Mild agitation, hallucinations and confusionAgitated delirium, psychosis, hallucinations, seizures, hyperthermia and coma

Open in a separate window

Indeed, in most atropine poisonings there are only mild or moderate symptoms, where supportive management using pro re nata benzodiazepines for agitation or seizures is adequate.4820 There is also evidence that, if a patient can reliably protect their airway and there is recent (<1 h) ingestion of the atropine, activated charcoal may be of benefit.420

Physostigmine is a reversible cholinesterase inhibitor; it is a tertiary amine and can therefore cross the blood–brain barrier. This distinguishes it from neostigmine (a more polar quaternary amine), which is used much more commonly to augment reversal of neuromuscular blockade postsurgery or in the treatment of myasthenia gravis. Both drugs work by inhibiting the breakdown of acetylcholine. However, only physostigmine can reverse the significant cerebral effects and can therefore act as an antidote in atropine poisoning, increasing the concentration of acetylcholine to overcome the muscarinic receptor’s competitive inhibition with atropine. Therefore, some people recommend its use in moderate-to-severe poisonings.2021 This may lead to lower rates of intubations22 and, in one small trial, it was better at controlling delirium and agitation than were benzodiazepines.23 Physostigmine is limited, however, in three ways; first, it is a rare drug, meaning it is not always immediately available.420 Second, it has a short duration of action (45–60 min) when compared to atropine (elimination half-life 2 h). Third, it is contraindicated if there is co-ingestion of tricyclic antidepressants due to an increase in the rate of arrhythmias and seizures. Therefore, before using physostigmine, it is important to know the aetiology of the poisoning. It may have a role in helping avoid intubation in certain patients or confirming the suspected diagnosis, however, in most situations, supportive care with possible escalation to sedation and intubation is adequate.420

Fortunately, the patient made a full recovery from this incident. Before discharge from hospital, our psychological medicine team interviewed her and confirmed that, though the ingestion was deliberate, the very high dose was accidental and of non-suicidal intent. No long-term follow-up was required.

The use of A. belladonna in medicine has a long history. ‘Belladonna extract’ is described in the very first edition of the British Pharmacopoeia (1864).24 This text defined tincture of belladonna, utilising a preparation technique of belladonna leaf and ‘proof spirit’ (57% alcohol) in proportions of approximately 1:20.

The modern British Pharmacopoeia (BP) uses belladonna leaf and 70% alcohol in proportions of 1:10 to create Belladonna Tincture BP. 25 This standard demands that the tincture contain 0.3 mg alkaloid per ml calculated as hyoscyamine. Atropine is a racemic mixture of the optical isomers d and l-hyoscyamine, with the l-hyoscyamine isomer being biologically active. The usual dose of Belladonna Tincture BP is 0.5–2 mL, given several times a day, generally as a gastrointestinal antispasmodic.

In this case, the herbalist had access to an A. belladonna preparation supplied by a herbal tincture manufacturer. The manufacturing process employed is very similar to that described for Belladonna Tincture BP. One kilogram of dry belladonna leaf (wild collected) is macerated and cold percolated with 10 L of an alcohol solution. It is not clear how this use of a weaker alcohol solution (45%) affects the alkaloid content, if at all. The final liquor is filtered to remove particulate matter, first through a 10 μ filter, then again through a 1 μ filter, before being bottled for sale in 500 mL bottles.

It is worth noting that the sale of the product is entirely legal. The medicines (retail sale of herbal remedies) order 1977 SI 2130 makes provision for exemptions for herbalists, allowing them to be in possession of and to supply a wide range of products in the course of their practice. Herbal medicines can be sold/supplied by the herbalist following a one-to-one consultation between the herbal practitioner and the client, provided the prescription remains within dose and route of administration limits outlined in Part II of the order. The herbalist can also exceed these limits provided the prescription order generated is fulfilled in a registered pharmacy by or under the supervision of a pharmacist. There is no mandatory training or registration for individuals wishing to practice as a herbal practitioner, although there are several courses available and voluntary registration schemes run by the array of bodies that represent herbalists. Herbalists are able to obtain stock products from several manufacturers and distributors, in the absence of a specific state registration scheme.

In the present case, the bottle had been unopened prior to the incident, so it was possible to calculate the volume consumed—this was found to be approximately 50 mL. Using an estimate of 0.3 mg/mL alkaloid content, the patient dose was estimated to be in the region of 15 mg of alkaloid. Given that hyoscyamine readily becomes racemic during the extraction process, this would mean that the patient took approximately 15 mg of atropine orally, although there is clearly a significant margin for error. To help contextualise this, the exact fatal dose of atropine is not known, indeed it has a relatively large margin of safety (LD50 453 mg)113 however, 10–20 mg of atropine is incapacitating and, in children, doses of <10 mg have proved fatal.1

To the best of our knowledge, this is the first reported incident of life-threatening atropine poisoning from ingestion of purchased herbal tincture A. belladonna preparation in the world literature. The case provides an important warning about the easy and legal availability of potentially lethal preparations and therefore we have not only described the case but have also detailed the manufacture and purchase of the substance.

Learning points

  • The care of atropine poisoning is predominantly excellent supportive care with benzodiazepines to treat agitation, though administration of physostigmine should be considered. Patients may require intubation and ventilation for their agitation.

  • The presentation of an acute confusional state is common to the medical take and this case highlights the importance of obtaining a full drug history including use of herbal preparations.

  • Finally, and most significantly, our case highlights the availability of potentially lethal substances that are easily obtainable with relatively minimal legal safeguards or specifications relating to the herbal remedy industry.

The authors would like to acknowledge Hannah Smorzaniuk, pharmacist at the John Radcliffe Hospital, Oxford, who researched much of the data regarding the dosage of Belladona Tincture during the clinical case.

Contributors: AC was the lead author writing the case summary. AA provided the literature search on atropine poisoning and wrote large amounts of the discussion. MB provided the legal/procedural research on the production of herbalist tinctures and also wrote large amounts of the discussion. JD helped write the concluding statements and provided edits throughout the whole document.

Competing interests: None declared.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

1. Mowry JB, Spyker DA, Cantilena LR Jr et al..
2013 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila)
2014;52:1032–283. 10.3109/15563650.2014.987397 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

2. Family Practice Notebook. http://www.fpnotebook.com/neuro/pharm/AntchlnrgcTxcty. htm

3. Ramjan KA, Williams AJ, Isbister GK et al..
‘Red as a beet and blind as a bat’ Anticholinergic delirium in adolescents: lessons for the paediatrician. J Paediatr Child Health
2007;43:779–80. 10.1111/j.1440-1754.2007.01220.x [PubMed] [CrossRef] [Google Scholar]

4. Glatstein M, Alabdulrazzaq F, Scolnik D.
Belladonna alkaloid intoxication: the 10-year experience of a large tertiary care pediatric hospital. Am J Ther
2013: 10.1097/01.mjt.0000433940.91996.16 [PubMed] [Google Scholar]

5. Bogan R, Zimmermann T, Zilker T et al..
Plasma level of atropine after accidental ingestion of Atropa belladonna. ClinToxicol (Phila)
2009;47:602–4. 10.1080/15563650903058906 [PubMed] [CrossRef] [Google Scholar]

6. Mateo Montoya A, Mavrakanas N, Schutz JS.
Acute anticholinergic syndrome from Atropa belladonna mistaken for blueberries. Eur J Ophthalmol
2009;19:170–2. [PubMed] [Google Scholar]

7. Cikla U, Turkmen S, Karaca Y et al..
An Atropa belladonna L. poisoning with acute subdural hematoma. Hum Exp Toxicol
2011;30:1998–2001. 10.1177/0960327111407225 [PubMed] [CrossRef] [Google Scholar]

8. Heindl S, Binder C, Desel H et al..
[Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome]. Dtsch Med Wochenschr
2000;125:1361–5. 10.1055/s-2000-8178 [PubMed] [CrossRef] [Google Scholar]

9. Oerther S, Behrman AD, Ketcham S.
Herbal hallucinations: common abuse situations seen in the emergency department. J Emerg Nurs
2010;36:594–6. 10.1016/j.jen.2010.07.018 [PubMed] [CrossRef] [Google Scholar]

10. Larkin GL.
Occupational atropine poisoning via aerosol. Lancet
10.1016/0140-6736(91)90247-M [PubMed] [CrossRef] [Google Scholar]

11. Amitai Y, Almog S, Singer R et al..
Atropine poisoning in children during the Persian Gulf crisis. A national survey in Israel. JAMA
1992;268:630–2. 10.1001/jama.1992. 03490050078030 [PubMed] [CrossRef] [Google Scholar]

12. Tatsumi M, Groshan K, Blakely RD et al..
Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol
1997;340:249–58. 10.1016/S0014-2999(97)01393-9 [PubMed] [CrossRef] [Google Scholar]

13. Brunton L, Chabner B, Knollman B.
Goodman and Gilman’s The pharmacological basis of therapeutics. 12th edn
New York: McGraw-Hill Professional, 2010.
ISBN: 978-0-07-162442-8. [Google Scholar]

14. Schep LJ, Slaughter RJ, Beasley DM.
The clinical toxicology of metamfetamine. Clin Toxicol (Phila)
2010;48:675–94. 10.3109/15563650.2010.516752 [PubMed] [CrossRef] [Google Scholar]

15. Pagliaro L, Ann Marie P.
Pagliaros’ comprehensive guide to drugs and substances of abuse. Washington DC: American Pharmacists Association, 2004. [Google Scholar]

16. Dargan PI, Wallace CI, Jones AL.
An evidenced based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J
2002;19:206–9. 10.1136/emj.19.3.206 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

17. Boyer EW, Shannon M.
The Serotonin Syndrome. N Engl J Med
2005;352:1112–20. 10.1056/NEJMra041867 [PubMed] [CrossRef] [Google Scholar]

18. Dosi R, Ambaliya A, Joshi H et al..
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. BMJ Case Rep
2014;2014:pii: bcr2014204154
10.1136/bcr-2014-204154 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

19. Perry PJ, Wilborn CA.
Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Ann Clin Psychiatry
2012;24:155–62. [PubMed] [Google Scholar]

20. US National Library of Medicine. TOXNET. http://www.toxnet.nlm.nih.gov/cgi-bin/sis/search3/f?./temp/~8Vr2Cn:3

21. Ceha LJ, Presperin C, Young E et al..
Anticholinergic toxicity from nightshade berry poisoning responsive to physostigmine. J Emerg Med
1997;15:65–9. 10.1016/S0736-4679(96)00244-2 [PubMed] [CrossRef] [Google Scholar]

22. Watkins JW, Schwarz ES, Arroyo-Plasencia AM et al..
The use of physostigmine by toxicologists in anticholinergic toxicity. J Med Toxicol
2015;11:179–84. 10.1007/s13181-014-0452-x [PMC free article] [PubMed] [CrossRef] [Google Scholar]

23. Burns MJ, Linden CH, Graudins A et al..
A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med
2000;35:374–81. 10.1016/S0196-0644(00)70057-6 [PubMed] [CrossRef] [Google Scholar]

24. General Council of Medical Education and Registration of the United Kingdom. British Pharmacopoeia. London: Stoppiswoode and Co.

25. https://www.pharmacopoeia.com/

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

SBL Belladonna Mother Tincture Q: Buy bottle of 30 ml Mother Tincture at best price in India

sbl belladonna mother tincture q

SBL Pvt Ltd

55 Ratings

Combo offers for this product

Additional discount

Pack of 2

₹180. 6

14% offMRP₹210

Buy Pack

Additional discount

Pack of 3


17% offMRP₹315

Buy Pack

Combo offers for this product

Additional discount

Pack of 2

₹180.6₹21014% off

Buy Pack

Additional discount

Pack of 3

₹261.45₹31517% off

Buy Pack

Inclusive of all taxes

1 Bottle

of30 ml Mother Tincture

Add to cart

110020, New Delhi

Additional offers

Paytm Wallet: Pay with Paytm Wallet on Tata 1mg for ₹999 or more and get cashback up to ₹250. Offer ends 30th June 2023.

Show more

Information about SBL Belladonna Mother Tincture Q

SBL Belladonna Mother Tincture is a highly useful homeopathic remedy which has a potent effect on the nervous system and can be used to treat convulsion and to relieve pain various parts of the body. It is primarily used to treat serious cases of opium poisoning. It also has a marked effect on the respiratory system and is helpful in the treatment of spasmodic cough and bronchitis.

Key Ingredients:

Key Benefits:

  • Effective in the treatment of spasms of the gastrointestinal tracts
  • Relives issues in the bladder and biliary tract
  • Highly useful for patients suffering from rheumatic and arthritic pains
  • It relieves sharp pain in the stomach caused due to excess of digestive acid in the stomach
  • It is used to cure rigidity tremor and perspiration related to Parkinson’s disease
  • Highly useful in regulating actions of the nervous system such as sweating and salivation
  • It is also used to correct digestive and urinary digestive disorders

Directions For Use
Take 10 drops diluted in half cup water thrice a day or as directed by the physician.

Safety Information:

  • Read the label carefully before use
  • Do not exceed the recommended dose
  • Keep out of the reach of children
  • Store in a cool dry place away from direct sunlight and heat

55 Ratings

Other Information

  • Cash on delivery available

Manufacturer/Marketer address

SBL, House 2 ,Commercial Complex, Shrestah Vihar,Delhi 10092,INDIA

Country of origin: India
Expires on or after: December, 2025

A licensed vendor partner from your nearest location will deliver SBL Belladonna Mother Tincture Q. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you.

In case of any issues, contact us

Email ID:[email protected]
Address: 5th Floor Tower – B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India

Stressful life?
Stay on top of your Health with our

Preventive Health Packages



  • Authentic Products

  • Great Savings

  • Home Delivery

Have issue with the content?

Report Problem

Oral gastric drops bottle 25 ml: instructions, price, analogues | oral drops Unipharma

  • Pharmacological properties
  • Readings
  • Contraindications
  • Interaction with other medicinal products and other forms of interaction
  • Dosage and Administration
  • Overdose
  • Adverse reactions
  • Expiry date
  • Storage conditions
  • Diagnosis
  • Recommended alternatives
  • Trade names



active ingredients: 1 ml of the drug contains tincture of valerian (Valerianae tinctura) (1: 5) (extractant – ethanol 70%) – 0. 4 ml, wormwood tincture ( Absinthii tinctura) ( 1: 5) (extractant – ethanol 70%) – 0.3 ml, peppermint tincture (Menthae piperitae tinctura) (1:20) (extractant – ethanol 90%) – 0.2 ml, belladonnae tinctura tincture ( 1:10) (extractant – ethanol 40%) – 0.1 ml.

Dosage form

Oral drops.

Basic physical and chemical properties: red-brown liquid, characteristic odor. During storage, precipitation may occur.

Pharmacotherapeutic group

Means used for functional disorders of the gastrointestinal tract.

ATX code A03B.

Pharmacological properties


The analgesic effect of drops in case of gastralgia is due to the action of belladonna alkaloids. The drug has a moderate antispasmodic effect, has a sedative effect due to valerian and peppermint, which are part of the drug, wormwood tincture normalizes the functions of the stomach, reflexively causes an increase in the secretion of gastric juice, and improves the digestion process.


Not studied.

Clinical characteristics


Gastralgia, non-ulcer dyspepsia, chronic gastritis with decreased secretory function of the stomach, biliary dyskinesia of the hyperkinetic type.


Hypersensitivity to the components of the drug.

Diseases of the gastrointestinal tract, accompanied by obstruction, increased gastric secretion, peptic ulcer of the stomach and duodenum, reflux esophagitis. Cholelithiasis. Urinary retention or predisposition to it.

Diseases of the cardiovascular system, in which an increase in heart rate is undesirable: atrial fibrillation; tachycardia, chronic heart failure, ischemic heart disease, mitral stenosis, severe arterial hypertension. Glaucoma.

Epilepsy, depression and other diseases accompanied by depression of the central nervous system.

Bronchial asthma. Spasmophilia. Myasthenia. hyperthermia syndrome. thyrotoxicosis. Acute bleeding. A history of bleeding from the pelvic organs. Anemia.

Interaction with other medicinal products and other types of interactions

Valerian, which is part of the medicinal product, may increase the effect of sedatives, hypnotics, analgesics, antispasmodics and cardiac drugs.

belladonna alkaloids reduce or stop the action of m cholinomimetics, anticholinesterase substances, potentiate the arrhythmogenic effect of MAO inhibitors, cardiac glycosides, clonidine, anticholinergic properties of quinidine, novocainamide, the effects of barbiturates, adrenomimetics, antihistamines, tranquilizers. With lead acetate, calcium salts, tannin, tincture of lily of the valley, the preparation forms precipitates.

Application features.

Patients with gastroesophageal reflux (heartburn) should avoid the use of the drug because heartburn may increase.

Non-compliance with the recommendations for the use of the medicinal product may be harmful to health.

The effect of the drug is reduced in persons who smoke and consume spicy and hot food.

Use during pregnancy or lactation.

Do not use during pregnancy and lactation.

The ability to influence the reaction rate when driving vehicles or operating other mechanisms.

During the treatment period, you should refrain from driving and performing work that requires increased attention and speed of reaction.

Dosage and Administration

Adults and children over 12 years of age take 15-30 drops orally with a small amount of boiled water 3-4 times a day half an hour before meals. The duration of the course of treatment is determined by the doctor, depending on the effect achieved and the tolerability of the drug.


The drug is contraindicated in children under 12 years of age.


Symptoms: increased manifestations of adverse reactions, headache, dizziness, general weakness, nausea, vomiting, abdominal pain, tachycardia, lowering blood pressure, agitation, irritability, tremor, insomnia, hyperthermia, depression of the central nervous system , decreased acuity of hearing and vision, suppression of the activity of the respiratory and vascular centers, loss of consciousness.

Treatment. Stop using the drug immediately. Gastric lavage, parenteral administration of cholinomimetics and anticholinesterase agents. Treatment is symptomatic.

Adverse reactions

In case of individual hypersensitivity to the components of the drug, local allergic reactions may develop (rash, itching, redness and swelling of the skin).

From the side of the nervous system: drowsiness, depression of emotional reactions, mental depression.

From the gastrointestinal tract: dry mouth, thirst, taste disturbance, dysphagia, decreased intestinal motility to atony, decreased tone of the biliary tract and gallbladder, nausea, vomiting, abdominal cramps.

From the side of the kidneys and urinary tract: difficulty and retention of urination.

Cardiac disorders: palpitations; arrhythmia, including extrasystole; myocardial ischemia.

Vascular disorders: flushing of the face, sensation of flushing.

Neurological disorders: headache, dizziness, dysarthria. Prolonged use can cause so-called wormwood epilepsy.

On the part of the organs of vision: dilated pupils, photophobia, accommodation paralysis, increased intraocular pressure.

On the part of the respiratory system and mediastinal organs: decrease in secretory activity and tone of the bronchi, which leads to the formation of viscous sputum, coughs heavily.

From the side of the skin and subcutaneous tissue: urticaria, exfoliative dermatitis, hyperemia.

From the immune system: anaphylactic reactions, angioedema, anaphylactic shock.

Others: decreased sweating, dry skin, reduced performance, weakness.

In case of any adverse effects, you should consult a doctor.

Shelf life

3 years.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 ° C.

Keep out of the reach of children.


25 ml in dropper bottles or bottles (with or without pack).

Dispensing category

Without a prescription.


Ternopharm LLC.

Location of the manufacturer and address of the place of business / location of the applicant

Ternopharm LLC.

Ukraine, 46010, Ternopil, st. Factory, 4.

Zelenina drops


medical medicinal product

Zelenina drops

900 30


active ingredients: 1 ml contains: belladonna tincture (Belladonnae folium aut herba) (1:10) (extractant – ethanol 40%) – 0.2 ml lilies of the valley tincture (Convallariae herba) (1:10) (extractant – ethanol 70%) – 0. 4 ml valerian tincture (Valerianae rhizoma cum radicibus) (1: 5) (extractant – ethanol 70%) – 0.4 ml menthol – 0.008 g.

Medical form . Drops oral.

Basic physical and chemical properties: green or yellow-brown liquid with a characteristic odor. During storage, precipitation may occur.

Pharmacological group. Various cardiac preparations.

ATC code C01E X.

Pharmacological properties.

Pharmacological. Combined herbal preparation. The components of the tinctures reduce the excitability of the central nervous system, have an antispasmodic effect, a slight cardiotonic effect, and increase the heart rate.

Valeric acid has a calming effect on the central nervous system. The belladonna tincture blocks the M-cholinergic receptors of the smooth muscles of the internal organs, as a result of which it has an antispasmodic effect. Menthol, irritating the mucous membrane of the oral cavity, reflexively expands the coronary vessels.

Pharmacokinetics. Not studied.

Clinical characteristics.


Neurocirculatory dystonia, bradycardia.


Glaucoma, organic lesions of the heart and blood vessels, prostatic hypertrophy, individual intolerance to the drug.

Interaction with other drugs and other forms of interaction.

The drug enhances the effect of sedatives, hypnotics, neuroleptics, tranquilizers on the central nervous system, cardiotonics, analgesics. Reduces the effect of antiarrhythmic drugs, which are prescribed for tachycardia.

Application features.

Elderly people and children over 12 years of age should use Zelenina Drops with caution due to the content of belladonna tincture in the preparation.

Use during pregnancy or lactation.

Do not use during pregnancy and lactation.

The ability to influence the reaction rate when driving vehicles or operating other mechanisms.

During the treatment period, you should refrain from driving vehicles or working with mechanisms.

Dosage and administration.

Inside, apply 20-25 drops 2-3 times a day, diluting with a small amount of water. Children over 12 years old – at the rate of 1 drop per 1 year of life 2-3 times a day. The duration of the course of treatment is determined by the doctor.


Do not use in children under 12 years of age.


There may be palpitations, dry mouth, disturbance of accommodation, dilated pupils, headache, dizziness, general weakness, nausea, tachycardia. If signs of an overdose are found, it is necessary to stop using the drug and consult a doctor for symptomatic therapy.